Nevia Bio
Nevia Bio provides non-invasive tests that detect gynecologic cancers early by analyzing vaginal secretions. It uses AI and machine learning with multi-omics data to identify disease biomarkers from vaginal fluid. The tests are designed for patient self-collection, reducing the need for invasive procedures and clinic visits. It targets diagnostics for gynecologic cancers and partners with healthcare providers to enable earlier treatment decisions. The approach aims to scale across gynecologic malignancies, expanding beyond ovarian cancer as validation grows.
Nevia Bio
Nevia Bio provides non-invasive tests that detect gynecologic cancers early by analyzing vaginal secretions. It uses AI and machine learning with multi-omics data to identify disease biomarkers from vaginal fluid. The tests are designed for patient self-collection, reducing the need for invasive procedures and clinic visits. It targets diagnostics for gynecologic cancers and partners with healthcare providers to enable earlier treatment decisions. The approach aims to scale across gynecologic malignancies, expanding beyond ovarian cancer as validation grows.